Simplify Logo

Full-Time

Patient and Community Educator

Northeast

Confirmed live in the last 24 hours

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Consulting
Biotechnology

Compensation Overview

$136k - $170kAnnually

+ Bonus + Equity Awards

Senior, Expert

Boston, MA, USA + 5 more

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Marketing
Requirements
  • Bachelor of Science in healthcare field strongly preferred with a minimum of 8 years’ experience in a similar role within the pharmaceutical/biotech industry.
  • Bachelor’s Degree (required)
  • Prior experience in patient education, clinical setting, pharmacy or community health education preferred
  • Experience supporting and providing education to patients, family members, and community groups affected by rare diseases
  • Demonstrated communication skills, including ability to deliver and present both virtually and in person
  • Exceptional interpersonal skills, professional communications, problem-solving, compassion and the ability to navigate difficult conversations
  • Ability to translate scientific/medical information into patient-friendly language
  • Desire to innovate and work in a fast-paced, energetic environment
  • Self-starter who is highly passionate about rare disease
  • Strong understanding of industry legal, regulatory, and compliance landscape
  • Fluent in both English and Spanish is a plus
Responsibilities
  • Identify and lead regional education efforts to provide disease-state and treatment education to patients, Caregivers, Care team members and community groups
  • Engage with Patient Advocacy groups to impact education of Acadia product(s) for Rett syndrome
  • Act as a commercial liaison on caregiver engagement across departments including Sales, Medical Affairs, Advocacy and Marketing
  • Understands individual needs of patients and Caregivers and develops an appropriate education and resource plan of action
  • Provides 1:1 education through virtual and in-person meetings
  • Manages caregiver mentor program
  • Executes educational programs in person through regional events and virtually through webinar events
  • Interprets and translates scientific clinical data into patient-friendly language
  • Moderates Caregiver Speaker programs coordinating all speakers: HCP, Family Access Manager and Caregiver Speakers
  • Contributes to Caregiver Speaker program strategy, content exploration and development, speaker identification, selection and utilization
  • Partners with Advocacy and sales team to identify opportunities for programs
  • Act as lead for speaker development and feedback including coaching and point of contact for any speaker program issues and updates
  • Support speaker program, webcast, and other key launch/marketing tactics
  • Support marketing team on Caregiver advisory board planning with the identification, coordination and contracting of appropriate attendees
  • Monitors Caregiver opinions and sentiment about current treatment patterns that may impact Acadia and provide feedback for consideration in the development of brand strategic plans
  • Identifies and summarizes key insights from events
  • Identifies educational gaps and insights that help inform the refinement and development of patient education resources
  • Measures the impact of PEL marketing activities on a continual basis and adjusts course where appropriate
  • Develops and delivers presentations as needed to commercial management and other internal groups
  • Actively collaborates with Field Sales, Patient Services, Medical Affairs, Marketing, Advocacy and other critical internal teams to increase disease-state awareness and early diagnosis
  • Maintains disease-state and product expertise through continuing medical education and attendance at relevant symposia, conferences and other educational opportunities
  • Ensures that all actions, both internally and externally working on Acadia’s behalf are in compliance with all laws regulations, policies and demonstrates Acadia values
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.